top of page
Canurta Website Images.jpg

Leading with Innovative Inflammation Recovery

Canurta Therapeutics is focused on innovative therapies in the areas of inflammation and neurology that hold great potential to alleviate symptoms and control disease progression.

 

Our lead candidates, Cannflavins A and B, are rare polyphenolic compounds scientifically shown to have 30x more anti-inflammatory power than NSAIDs. 

By championing the multitarget qualities of polyphenols, we can address a variety of disease targets with multiple physiological determinants. 

potency_ylw_2x-8.png

Canurta’s Therapy Areas

Corporate Deck - October 2023 Updates.png

CNR-100s: Inflammation

Inflammation is mediated in our bodies in different ways. The two pathways most often targeted are called the prostaglandin pathway, and the lipoxygenase pathway. Many drugs used to treat inflammation are designed to inhibit or shut down only one pathway. This prevents the production of some proinflammatory molecules but leaves room for inflammation to manifest.

What if we could find a way to inhibit both pathways at the same time? Well, you would have a very powerful anti-inflammatory that can block inflammation from two key mediators.

Canurta’s CNR-100 assets make dual inhibition possible, offering botanical solutions that can eliminate the production of proinflammatory molecules.

CNR-100 candidates are designed to target chronic inflammatory conditions such as rheumatoid arthritis, juvenile arthritis, atherosclerosis, respiratory diseases and vascular diseases.

CNR-100

CNR-400s: Neurology

Researchers have learned that polyphenols can play an important role in protecting our brain cells. Yet most sources of polyphenols can lack bioavailability and access to rarer, therapeutic compounds. 

Canurta proprietary technologies identify and extract rare polyphenols at high-potencies to develop therapeutics that can defend against neurodegenerative diseases and treat emerging symptoms. 

This defence targets two enzymes called MAGL and FAAH. These enzymes produce a substance called arachidonic acid that can lead to inflammation. And we know inflammation can contribute to the progression of neurodegenerative diseases. 

Canurta’s CNR-400 therapeutics can stop these enzymes in their tracks, safeguarding brain cells by stopping harmful, inflammatory processes.

CNR-400

A Continuum of Care starts with Nutraceuticals

Building both innovative botanical drugs and nutraceutical products allows us to leverage the multi-potent benefits of our polyphenolic compounds to meet both daily supplement needs and the demand for next-generation botanical drugs.

 

Canurta’s nutraceuticals will serve as the foundation for prevention and management, while our botanical drugs focus on treatment, addressing specific diseases.

Nutraceuticals

Activated Seed Powders

Canurta’s Activated Hemp Seed Powder has the highest concentration of hemp seed polyphenols for inflammation and antioxidant support.

Using a proprietary activation process, Activated Hemp Seed Powder has optimized digestibility and bioavailability of essential vitamins and minerals as compared to conventional hemp seed powders. This process also enhances the formation of polyphenolic molecules, providing unparalleled access to vital compounds, surpassing conventional hemp seed powders.

1.png

Joint Mobility

4.png

Antioxidant Support

3.png

Stiffness

2.png

Vitamins and Minerals

CanurtaNaturalsPowderwithshadow.png

Polyphenol Extract

Canurta’s polyphenol extract is a patented polyphenol extract clinically shown to manage inflammation, address acute pain and improve skin health.

Using a proprietary extraction process that detects, isolates, and purifies rare hemp polyphenols such as Cannflavins in the highest concentration available, Polyphenol Extract is a potent ingredient with a unique profile.

5.png

Pain

7.png

Inflammation

1.png

Joint Mobility

6.png

Skin Care

8.png

Headaches

3.png

Stiffness

CN_Extract_2.png
bottom of page